Fox Run Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Buy
23,397
+18,364
+365% +$1.48M 0.3% 35
2026
Q1
$432K Buy
+5,033
New +$482K 0.08% 509
2024
Q3
Sell
-17,399
Closed -$1.37M 984
2024
Q2
$1.37M Buy
+17,399
New +$1.43M 0.26% 90
2024
Q1
Sell
-6,081
Closed -$501K 953
2023
Q4
$501K Buy
+6,081
New +$463K 0.13% 298
2023
Q3
Sell
-5,071
Closed -$447K 871
2023
Q2
$447K Buy
+5,071
New +$437K 0.13% 322
2022
Q4
Sell
-5,451
Closed -$440K 783
2022
Q3
$440K Buy
+5,451
New +$490K 0.17% 215
2021
Q4
Sell
-8,644
Closed -$1.08M 608
2021
Q3
$1.08M Buy
8,644
+3,919
+83% +$507K 0.68% 3
2021
Q2
$587K Buy
+4,725
New +$593K 0.53% 19
2020
Q2
Sell
-4,263
Closed -$384K 297
2020
Q1
$384K Buy
+4,263
New +$454K 0.91% 10
2019
Q3
Sell
-4,957
Closed -$483K 486
2019
Q2
$483K Buy
+4,957
New +$453K 0.32% 83
2019
Q1
Sell
-2,748
Closed -$250K 604
2018
Q4
$250K Buy
+2,748
New +$257K 0.13% 330
2018
Q2
Sell
-16,698
Closed -$1.34M 817
2018
Q1
$1.34M Buy
16,698
+9,259
+124% +$764K 0.32% 27
2017
Q4
$601K Buy
+7,439
New +$596K 0.18% 224
2017
Q1
Sell
-3,000
Closed -$214K 686
2016
Q4
$214K Buy
+3,000
New +$236K 0.11% 411
2016
Q3
Sell
-5,500
Closed -$477K 605
2016
Q2
$477K Buy
+5,500
New +$445K 0.23% 144
2016
Q1
Sell
-3,700
Closed -$285K 500
2015
Q4
$285K Buy
+3,700
New +$279K 0.22% 182

Other funds holding MDT

Fox Run Management's MDT Position: Q2 2026 in Review

Fox Run Management increased its Medtronic (MDT) stake by 365% in Q2 2026, buying an estimated $1.48M and bringing the position to 23,397 shares worth $1.83M. The position accounts for 0.3% of the portfolio, ranked #35.

Fox Run Management first reported a position in MDT in Q4 2015 and has held it in 16 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fox Run Management held 23,397 shares of Medtronic worth $1.83M as of Q2 2026.
  • Fox Run Management bought 18,364 Medtronic shares in Q2 2026, an estimated $1.48M.
  • Medtronic made up 0.3% of Fox Run Management's portfolio in Q2 2026, its #35 holding.
  • Fox Run Management first reported a position in Medtronic in Q4 2015 and has held it in 16 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.